This retrospective study demonstrated that the reversion mutations were observed in three HRR-associated genes (BRCA1, BRCA2 and PALB2) with four cancer types (breast cancer, pancreatic cancer, ovarian cancer, and lung cancer) from this Chinese pan-cancer patient cohort. This evidence concerns the gene PALB2 and familial pancreatic carcinoma.